BMND8
MCID: BNM022
MIFTS: 43

Bone Mineral Density Quantitative Trait Locus 8 (BMND8)

Categories: Bone diseases, Fetal diseases, Genetic diseases, Rare diseases

Aliases & Classifications for Bone Mineral Density Quantitative Trait Locus 8

MalaCards integrated aliases for Bone Mineral Density Quantitative Trait Locus 8:

Name: Bone Mineral Density Quantitative Trait Locus 8 57
Osteoporosis 57 72
Osteoporosis, Susceptibility to 57
Bmnd8 57

Classifications:



External Ids:

OMIM 57 611739
UMLS 72 C0029456

Summaries for Bone Mineral Density Quantitative Trait Locus 8

MalaCards based summary : Bone Mineral Density Quantitative Trait Locus 8, also known as osteoporosis, is related to osteoporosis and osteoporosis, juvenile, and has symptoms including tremor, angina pectoris and back pain. An important gene associated with Bone Mineral Density Quantitative Trait Locus 8 is BMND8 (Bone Mineral Density Quantiative Trait Locus 8). The drugs Linagliptin and Magnesium oxide have been mentioned in the context of this disorder. Affiliated tissues include bone, breast and prostate.

More information from OMIM: 611739

Related Diseases for Bone Mineral Density Quantitative Trait Locus 8

Diseases in the Bone Mineral Density Quantitative Trait Locus 15 family:

Bone Mineral Density Quantitative Trait Locus 4 Bone Mineral Density Quantitative Trait Locus 18
Bone Mineral Density Quantitative Trait Locus 1 Bone Mineral Density Quantitative Trait Locus 2
Bone Mineral Density Quantitative Trait Locus 3 Bone Mineral Density Quantitative Trait Locus 5
Bone Mineral Density Quantitative Trait Locus 6 Bone Mineral Density Quantitative Trait Locus 7
Bone Mineral Density Quantitative Trait Locus 8 Bone Mineral Density Quantitative Trait Locus 9
Bone Mineral Density Quantitative Trait Locus 10 Bone Mineral Density Quantitative Trait Locus 11
Bone Mineral Density Quantitative Trait Locus 12 Bone Mineral Density Quantitative Trait Locus 13
Bone Mineral Density Quantitative Trait Locus 14 Bone Mineral Density Quantitative Trait Locus 16
Bone Mineral Density Quantitative Trait Locus 17

Diseases related to Bone Mineral Density Quantitative Trait Locus 8 via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 1037, show less)
# Related Disease Score Top Affiliating Genes
1 osteoporosis 13.2
2 osteoporosis, juvenile 12.9
3 osteoporosis-pseudoglioma syndrome 12.8
4 nephrolithiasis/osteoporosis, hypophosphatemic, 1 12.6
5 glucocorticoid-induced osteoporosis 12.6
6 juvenile primary osteoporosis 12.6
7 nephrolithiasis/osteoporosis, hypophosphatemic, 2 12.5
8 osteoporosis and oculocutaneous hypopigmentation syndrome 12.5
9 macroepiphyseal dysplasia with osteoporosis, wrinkled skin, and aged appearance 12.3
10 growth failure, microcephaly, mental retardation, cataracts, large joint contractures, osteoporosis, cortical dysplasia, and cerebellar atrophy 12.2
11 dominant hypophosphatemia with nephrolithiasis or osteoporosis 12.2
12 bone mineral density quantitative trait locus 15 12.2
13 amino aciduria with mental deficiency, dwarfism, muscular dystrophy, osteoporosis, and acidosis 12.2
14 hajdu-cheney syndrome 12.1
15 cutis laxa osteoporosis 12.1
16 osteoporosis-macrocephaly-blindness-joint hyperlaxity syndrome 12.1
17 lrp5-related primary osteoporosis 12.1
18 bone mineral density quantitative trait locus 18 12.0
19 acroosteolysis dominant type 12.0
20 bone mineral density quantitative trait locus 16 11.8
21 premature ovarian failure 1 11.6
22 aromatase deficiency 11.6
23 bone mineral density quantitative trait locus 12 11.6
24 bone disease 11.6
25 werner syndrome 11.6
26 syndromic x-linked intellectual disability snyder type 11.6
27 lysinuric protein intolerance 11.5
28 mental retardation, x-linked, syndromic, snyder-robinson type 11.5
29 geroderma osteodysplasticum 11.5
30 hyperparathyroidism 11.5
31 rickets 11.5
32 premature aging syndrome, okamoto type 11.4
33 cerebrotendinous xanthomatosis 11.4
34 acth-secreting pituitary adenoma 11.4
35 cholangitis, primary sclerosing 11.4
36 spondyloocular syndrome 11.4
37 cleidocranial dysplasia 11.4
38 anorexia nervosa 11.4
39 celiac disease 1 11.4
40 systemic mastocytosis 11.4
41 osteopetrosis 11.3
42 hypogonadotropic hypogonadism 11.3
43 graves' disease 11.3
44 severe congenital neutropenia 11.3
45 turner syndrome 11.3
46 pituitary adenoma 4, acth-secreting 11.3
47 homocystinuria 11.3
48 exudative vitreoretinopathy 11.3
49 spinal disease 11.3
50 cleft palate, isolated 11.3
51 menkes disease 11.3
52 parathyroid carcinoma 11.3
53 dyskeratosis congenita 11.3
54 kallmann syndrome 11.3
55 47, xxy 11.3
56 multicentric osteolysis, nodulosis, and arthropathy 11.3
57 winchester syndrome 11.3
58 bone resorption disease 11.2
59 epiphyseal dysplasia, multiple, with early-onset diabetes mellitus 11.2
60 mucolipidosis iii alpha/beta 11.2
61 nestor-guillermo progeria syndrome 11.2
62 dyskeratosis congenita, autosomal recessive 1 11.1
63 hyaline fibromatosis syndrome 11.1
64 mucolipidosis iii gamma 11.1
65 prader-willi habitus, osteopenia, and camptodactyly 11.1
66 osteogenesis imperfecta, type xii 11.1
67 dyskeratosis congenita, autosomal dominant 2 11.1
68 osteogenesis imperfecta, type xiii 11.1
69 dyskeratosis congenita, autosomal recessive 5 11.1
70 pigmented nodular adrenocortical disease, primary, 4 11.1
71 dyskeratosis congenita, autosomal dominant 6 11.1
72 ehlers-danlos syndrome, classic-like, 2 11.1
73 familial isolated hyperparathyroidism 11.1
74 dyskeratosis congenita, autosomal dominant 1 11.0
75 hyperparathyroidism 2 with jaw tumors 11.0
76 singleton-merten syndrome 1 11.0
77 aspartylglucosaminuria 11.0
78 cardiomyopathy, dilated, with hypergonadotropic hypogonadism 11.0
79 acth-independent macronodular adrenal hyperplasia 11.0
80 polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1 11.0
81 achalasia-addisonianism-alacrima syndrome 11.0
82 glycogen storage disease ia 11.0
83 growth hormone insensitivity with immunodeficiency 11.0
84 diarrhea 2, with microvillus atrophy 11.0
85 bruck syndrome 1 11.0
86 parana hard-skin syndrome 11.0
87 rothmund-thomson syndrome 11.0
88 spondyloepimetaphyseal dysplasia, sponastrime type 11.0
89 dyskeratosis congenita, x-linked 11.0
90 kallmann syndrome with spastic paraplegia 11.0
91 stuve-wiedemann syndrome 11.0
92 pigmented nodular adrenocortical disease, primary, 2 11.0
93 pigmented nodular adrenocortical disease, primary, 1 11.0
94 osteogenesis imperfecta, type viii 11.0
95 dyskeratosis congenita, autosomal recessive 2 11.0
96 dyskeratosis congenita, autosomal recessive 3 11.0
97 dyskeratosis congenita, autosomal dominant 3 11.0
98 pigmented nodular adrenocortical disease, primary, 3 11.0
99 intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies 11.0
100 estrogen resistance 11.0
101 acth-independent macronodular adrenal hyperplasia 2 11.0
102 dyskeratosis congenita, autosomal recessive 6 11.0
103 thrombocytopenia 6 11.0
104 ovarian dysgenesis 8 11.0
105 primary pigmented nodular adrenocortical disease 11.0
106 46 xy gonadal dysgenesis 11.0
107 atypical werner syndrome 11.0
108 congenital analbuminemia 11.0
109 fmr1-related primary ovarian insufficiency 11.0
110 neonatal adrenoleukodystrophy 11.0
111 singleton-merten syndrome 11.0
112 idiopathic infantile hypercalcemia 11.0
113 bone mineral density quantitative trait locus 3 10.9
114 osteoarthritis 10.8
115 osteonecrosis 10.8
116 hypogonadism 10.8
117 hypogonadotropism 10.8
118 osteomalacia 10.8
119 back pain 10.7
120 osteonecrosis of the jaw 10.7
121 rheumatoid arthritis 10.7
122 secondary hyperparathyroidism 10.6
123 arthritis 10.6
124 mammary paget's disease 10.6
125 col1a1/2-related osteogenesis imperfecta 10.6
126 triiodothyronine receptor auxiliary protein 10.6
127 brittle bone disorder 10.6
128 primary hyperparathyroidism 10.6
129 hyperthyroidism 10.6
130 inflammatory bowel disease 10.6
131 body mass index quantitative trait locus 1 10.5
132 amenorrhea 10.5
133 periodontitis 10.5
134 diabetes mellitus 10.5
135 pulmonary disease, chronic obstructive 10.5
136 inflammatory spondylopathy 10.5
137 spondylitis 10.5
138 chronic kidney disease 10.5
139 spondyloarthropathy 1 10.5
140 thalassemia 10.5
141 insulin-like growth factor i 10.4
142 liver disease 10.4
143 spinal cord injury 10.4
144 mastocytosis 10.4
145 aging 10.4
146 prostate cancer 10.4
147 alcohol use disorder 10.4
148 liver cirrhosis 10.4
149 kidney disease 10.4
150 arterial calcification, generalized, of infancy, 1 10.4
151 avascular necrosis 10.4
152 sclerosteosis 10.4
153 chronic pain 10.4
154 endometrial cancer 10.4
155 primary biliary cholangitis 10.4
156 myeloma, multiple 10.4
157 rheumatic disease 10.4
158 alcohol dependence 10.4
159 autoimmune disease 10.4
160 primary biliary cirrhosis 10.4
161 crohn's disease 10.4
162 breast cancer 10.3
163 atherosclerosis susceptibility 10.3
164 lipid metabolism disorder 10.3
165 hypothyroidism 10.3
166 arthropathy 10.3
167 scoliosis 10.3
168 lung disease 10.3
169 nephrolithiasis, calcium oxalate 10.3
170 paget's disease of bone 10.3
171 cystic fibrosis 10.3
172 osteogenic sarcoma 10.3
173 body mass index quantitative trait locus 11 10.3
174 body mass index quantitative trait locus 9 10.3
175 body mass index quantitative trait locus 8 10.3
176 body mass index quantitative trait locus 4 10.3
177 body mass index quantitative trait locus 10 10.3
178 body mass index quantitative trait locus 7 10.3
179 body mass index quantitative trait locus 12 10.3
180 body mass index quantitative trait locus 14 10.3
181 body mass index quantitative trait locus 18 10.3
182 body mass index quantitative trait locus 19 10.3
183 body mass index quantitative trait locus 20 10.3
184 graves disease 1 10.3
185 beta-thalassemia 10.3
186 renal osteodystrophy 10.3
187 eating disorder 10.3
188 systemic lupus erythematosus 10.3
189 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.3
190 47,xyy 10.3
191 hemosiderosis 10.3
192 rare hereditary hemochromatosis 10.3
193 fibrosis of extraocular muscles, congenital, 1 10.3
194 yemenite deaf-blind hypopigmentation syndrome 10.2
195 hydrops, lactic acidosis, and sideroblastic anemia 10.2
196 synovitis 10.2
197 endometrial hyperplasia 10.2
198 hyperglycemia 10.2
199 lupus erythematosus 10.2
200 coronary heart disease 1 10.2
201 vascular disease 10.2
202 connective tissue disease 10.2
203 rapidly involuting congenital hemangioma 10.2
204 endosteal hyperostosis, autosomal dominant 10.2
205 temporal arteritis 10.2
206 autosomal recessive disease 10.2
207 premature menopause 10.2
208 paraplegia 10.2
209 muscular dystrophy 10.2
210 lactose intolerance 10.2
211 acromegaly 10.2
212 depression 10.2
213 lymphocytic leukemia 10.2
214 cholestasis 10.2
215 urticaria 10.2
216 cerebral palsy 10.2
217 enthesopathy 10.2
218 cerebrovascular disease 10.2
219 peptic ulcer disease 10.2
220 ulcerative colitis 10.2
221 acroosteolysis 10.2
222 hypercholesterolemia, familial, 1 10.2
223 spondylolisthesis 10.2
224 hypogonadism, male 10.2
225 hyperprolactinemia 10.2
226 osteomyelitis 10.2
227 hypoparathyroidism 10.2
228 heart disease 10.2
229 esophagitis 10.2
230 algoneurodystrophy 10.2
231 muscular atrophy 10.2
232 gastrointestinal system disease 10.2
233 reflex sympathetic dystrophy 10.1
234 leukemia, acute lymphoblastic 10.1
235 vitamin k deficiency bleeding 10.1
236 hyperostosis 10.1
237 gastritis 10.1
238 juvenile rheumatoid arthritis 10.1
239 pik3ca-related overgrowth syndrome 10.1
240 dermatomyositis 10.1
241 spondylosis 10.1
242 dermatitis 10.1
243 bone inflammation disease 10.1
244 congestive heart failure 10.1
245 cataract 10.1
246 growth hormone deficiency 10.1
247 idiopathic hypercalciuria 10.1
248 muscular dystrophy, duchenne type 10.1
249 deficiency anemia 10.1
250 benign paroxysmal positional nystagmus 10.1
251 constipation 10.1
252 arteriosclerosis 10.1
253 pemphigus 10.1
254 48,xyyy 10.1
255 rare disease in surgical orthopedic 10.1
256 thyroid carcinoma 10.1
257 multiple sclerosis 10.1
258 mastocytosis, cutaneous 10.1
259 homocysteinemia 10.1
260 psoriatic arthritis 10.1
261 hyperphosphatemia 10.1
262 hemiplegia 10.1
263 conn's syndrome 10.1
264 dyspepsia 10.1
265 myopathy 10.1
266 degenerative disc disease 10.1
267 alzheimer disease 10.1
268 gastroesophageal reflux 10.1
269 scleroderma, familial progressive 10.1
270 periodontitis, chronic 10.1
271 neutropenia 10.1
272 uveitis 10.1
273 impotence 10.1
274 ankylosis 10.1
275 pustulosis of palm and sole 10.1
276 adenoma 10.1
277 end stage renal failure 10.1
278 psoriasis 10.1
279 hypopituitarism 10.1
280 dysphagia 10.1
281 esophageal cancer 10.1
282 sarcoidosis 1 10.1
283 schizophrenia 10.1
284 hemochromatosis, type 1 10.1
285 asthma 10.1
286 immunodeficiency, common variable, 10 10.1
287 ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus 10.1
288 peripheral vascular disease 10.1
289 leukemia 10.1
290 nephrocalcinosis 10.1
291 diarrhea 10.1
292 renal tubular acidosis 10.1
293 hyperinsulinism 10.1
294 iron metabolism disease 10.1
295 complex regional pain syndrome 10.1
296 cellulitis 10.1
297 skin disease 10.1
298 fatty liver disease 10.1
299 cytokine deficiency 10.1
300 arteries, anomalies of 10.0
301 colorectal cancer 10.0
302 helicobacter pylori infection 10.0
303 pitt-hopkins syndrome 10.0
304 hypophosphatemia 10.0
305 metabolic acidosis 10.0
306 fibrous dysplasia 10.0
307 non-alcoholic fatty liver disease 10.0
308 gingival recession 10.0
309 gout 10.0
310 dental caries 10.0
311 bronchitis 10.0
312 vasculitis 10.0
313 cholangitis 10.0
314 premature aging 10.0
315 neurofibromatosis, type iv, of riccardi 10.0
316 hypoascorbemia 10.0
317 stroke, ischemic 10.0
318 creatinine clearance quantitative trait locus 10.0
319 gastric cancer 10.0
320 leukemia, acute lymphoblastic 3 10.0
321 exanthem 10.0
322 sleep apnea 10.0
323 colitis 10.0
324 childhood acute lymphocytic leukemia 10.0
325 respiratory failure 10.0
326 nephrotic syndrome 10.0
327 dementia 10.0
328 exostosis 10.0
329 idiopathic interstitial pneumonia 10.0
330 osteitis fibrosa 10.0
331 pulmonary fibrosis 10.0
332 rhinitis 10.0
333 indolent systemic mastocytosis 10.0
334 spinal stenosis 10.0
335 collagen disease 10.0
336 hemophilia 10.0
337 pemphigus vulgaris, familial 10.0
338 down syndrome 10.0
339 van buchem disease 10.0
340 myasthenia gravis 10.0
341 hyperlipoproteinemia, type iii 10.0
342 atrial fibrillation 10.0
343 idiopathic scoliosis 10.0
344 siderosis 10.0
345 coronary artery anomaly 10.0
346 allergic hypersensitivity disease 10.0
347 goiter 10.0
348 ehlers-danlos syndrome 10.0
349 calcinosis 10.0
350 hepatitis c 10.0
351 hyperuricemia 10.0
352 endometriosis 10.0
353 systemic scleroderma 10.0
354 poliomyelitis 10.0
355 fibromyalgia 10.0
356 monoclonal gammopathy of uncertain significance 10.0
357 septic arthritis 10.0
358 pulmonary embolism 10.0
359 bronchiectasis 10.0
360 syndrome of inappropriate antidiuretic hormone 10.0
361 diabetes mellitus, noninsulin-dependent 9.9
362 retinal detachment 9.9
363 leprosy 3 9.9
364 proteasome-associated autoinflammatory syndrome 1 9.9
365 pulmonary alveolar microlithiasis 9.9
366 pycnodysostosis 9.9
367 bulimia nervosa 9.9
368 hepatitis c virus 9.9
369 alacrima, achalasia, and mental retardation syndrome 9.9
370 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.9
371 sexual disorder 9.9
372 estrogen-receptor positive breast cancer 9.9
373 spondyloarthropathy 9.9
374 polycystic ovary syndrome 9.9
375 iron deficiency anemia 9.9
376 gonadal dysgenesis 9.9
377 epidermolysis bullosa 9.9
378 plasmacytoma 9.9
379 thyroid gland disease 9.9
380 infertility 9.9
381 intestinal disease 9.9
382 neuropathy 9.9
383 alopecia 9.9
384 hypoglycemia 9.9
385 hansen's disease 9.9
386 polymyositis 9.9
387 differentiated thyroid carcinoma 9.9
388 hematopoietic stem cell transplantation 9.9
389 rare surgical neurologic disease 9.9
390 hepatocellular carcinoma 9.9
391 hypertriglyceridemia, familial 9.9
392 migraine with or without aura 1 9.9
393 myositis 9.9
394 osteogenesis imperfecta, type i 9.9
395 pernicious anemia 9.9
396 scheuermann disease 9.9
397 trichorhinophalangeal syndrome, type i 9.9
398 lipoid congenital adrenal hyperplasia 9.9
399 ataxia and polyneuropathy, adult-onset 9.9
400 pituitary adenoma, prolactin-secreting 9.9
401 xanthomatosis 9.9
402 dermatitis, atopic 9.9
403 myocardial infarction 9.9
404 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.9
405 microvascular complications of diabetes 3 9.9
406 microvascular complications of diabetes 4 9.9
407 microvascular complications of diabetes 6 9.9
408 microvascular complications of diabetes 7 9.9
409 global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies 9.9
410 peripheral artery disease 9.9
411 lymphoma 9.9
412 crohn's colitis 9.9
413 infant gynecomastia 9.9
414 otosclerosis 9.9
415 gynecomastia 9.9
416 peptic esophagitis 9.9
417 childhood type dermatomyositis 9.9
418 thrombocytopenia 9.9
419 mental depression 9.9
420 autoimmune hepatitis 9.9
421 substance abuse 9.9
422 acute kidney failure 9.9
423 gingivitis 9.9
424 skin carcinoma 9.9
425 radiculopathy 9.9
426 neuromuscular disease 9.9
427 hypokalemia 9.9
428 epidermolysis bullosa dystrophica 9.9
429 pancreatitis 9.9
430 sleep disorder 9.9
431 peripheral nervous system disease 9.9
432 lymphopenia 9.9
433 parathyroid adenoma 9.9
434 pulmonary emphysema 9.9
435 irritable bowel syndrome 9.9
436 hemophilic arthropathy 9.9
437 splenomegaly 9.9
438 brain injury 9.9
439 hypotonia 9.9
440 spasticity 9.9
441 systemic autoimmune disease 9.9
442 overgrowth syndrome 9.9
443 calvarial doughnut lesions with bone fragility 9.8
444 neurofibromatosis, type i 9.8
445 mccune-albright syndrome 9.8
446 neural tube defects 9.8
447 spondylosis, cervical 9.8
448 thrombophilia due to thrombin defect 9.8
449 persistent hyperplastic primary vitreous, autosomal recessive 9.8
450 immune deficiency disease 9.8
451 hypophosphatemic rickets, x-linked recessive 9.8
452 mend syndrome 9.8
453 arts syndrome 9.8
454 rett syndrome 9.8
455 allergic rhinitis 9.8
456 major depressive disorder 9.8
457 major affective disorder 8 9.8
458 major affective disorder 9 9.8
459 premature ovarian failure 7 9.8
460 non-alcoholic steatohepatitis 9.8
461 sensorineural hearing loss 9.8
462 nasopharyngitis 9.8
463 microphthalmia 9.8
464 gastric ulcer 9.8
465 prostatic hypertrophy 9.8
466 quadriplegia 9.8
467 exocrine pancreatic insufficiency 9.8
468 sclerosing cholangitis 9.8
469 primary hypertrophic osteoarthropathy 9.8
470 candidiasis 9.8
471 epilepsy 9.8
472 viral hepatitis 9.8
473 hepatitis b 9.8
474 psychotic disorder 9.8
475 hemoglobinopathy 9.8
476 prostatic adenoma 9.8
477 acute pancreatitis 9.8
478 adenocarcinoma 9.8
479 testicular cancer 9.8
480 interstitial lung disease 9.8
481 bipolar disorder 9.8
482 mood disorder 9.8
483 purpura 9.8
484 pituitary adenoma 9.8
485 milk allergy 9.8
486 adrenal adenoma 9.8
487 herpes zoster 9.8
488 atrophic gastritis 9.8
489 amyloidosis 9.8
490 meningitis 9.8
491 hypervitaminosis d 9.8
492 trichorhinophalangeal syndrome 9.8
493 aminoaciduria 9.8
494 collagenopathy type 2 alpha 1 9.8
495 distal renal tubular acidosis 9.8
496 oncogenic osteomalacia 9.8
497 age-related hearing loss 9.8
498 autonomic dysfunction 9.8
499 hypoxia 9.8
500 syncope 9.8
501 traumatic brain injury 9.8
502 inflammatory myopathy with abundant macrophages 9.8
503 vitreoretinopathy 9.8
504 amyotrophic lateral sclerosis 1 9.7
505 bladder cancer 9.7
506 multiple endocrine neoplasia, type i 9.7
507 exostoses, multiple, type i 9.7
508 hand skill, relative 9.7
509 hernia, hiatus 9.7
510 hypercalciuria, absorptive, 2 9.7
511 hypercalcemia, infantile, 1 9.7
512 renal cell carcinoma, nonpapillary 9.7
513 hyperostosis frontalis interna 9.7
514 hypertension, essential 9.7
515 inclusion body myositis 9.7
516 marfan syndrome 9.7
517 ovarian cancer 9.7
518 polykaryocytosis inducer 9.7
519 prader-willi syndrome 9.7
520 hutchinson-gilford progeria syndrome 9.7
521 pulmonary fibrosis, idiopathic 9.7
522 scoliosis, isolated 1 9.7
523 adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency 9.7
524 diabetes mellitus, insulin-dependent 9.7
525 gaucher disease, type i 9.7
526 hypervitaminosis a 9.7
527 shwachman-diamond syndrome 1 9.7
528 pituitary hormone deficiency, combined, 2 9.7
529 hypothyroidism, congenital, nongoitrous, 4 9.7
530 fabry disease 9.7
531 taqi polymorphism 9.7
532 prostatic hyperplasia, benign 9.7
533 sickle cell anemia 9.7
534 langerhans cell histiocytosis 9.7
535 hypertension, early-onset, autosomal dominant, with severe exacerbation in pregnancy 9.7
536 huntington disease-like 2 9.7
537 anxiety 9.7
538 prostate cancer, hereditary, 4 9.7
539 intraocular pressure quantitative trait locus 9.7
540 microvascular complications of diabetes 5 9.7
541 fatty liver disease, nonalcoholic 1 9.7
542 graft-versus-host disease 9.7
543 bone mineral density quantitative trait locus 17 9.7
544 pulmonary hypertension 9.7
545 chlamydia pneumonia 9.7
546 brachydactyly 9.7
547 female breast cancer 9.7
548 vitamin b12 deficiency 9.7
549 progesterone-receptor positive breast cancer 9.7
550 pain agnosia 9.7
551 myelomeningocele 9.7
552 recessive dystrophic epidermolysis bullosa 9.7
553 stickler syndrome 9.7
554 silicosis 9.7
555 pre-eclampsia 9.7
556 glucose intolerance 9.7
557 short bowel syndrome 9.7
558 fanconi syndrome 9.7
559 renal hypertension 9.7
560 portal hypertension 9.7
561 hydrocephalus 9.7
562 cholesteatoma of middle ear 9.7
563 ovarian disease 9.7
564 hydronephrosis 9.7
565 sarcoma 9.7
566 chlamydia 9.7
567 blind hypotensive eye 9.7
568 visual epilepsy 9.7
569 low compliance bladder 9.7
570 secondary hyperparathyroidism of renal origin 9.7
571 acute leukemia 9.7
572 guillain-barre syndrome 9.7
573 dental fluorosis 9.7
574 adult-onset still's disease 9.7
575 angioedema 9.7
576 ectropion 9.7
577 endogenous depression 9.7
578 lymphadenitis 9.7
579 pneumothorax 9.7
580 cystitis 9.7
581 ichthyosis 9.7
582 duodenal ulcer 9.7
583 neuritis 9.7
584 bone cancer 9.7
585 gaucher's disease 9.7
586 vaginitis 9.7
587 lateral sclerosis 9.7
588 hemangioma 9.7
589 glomerulonephritis 9.7
590 antiphospholipid syndrome 9.7
591 lipomatosis 9.7
592 inappropriate adh syndrome 9.7
593 histiocytosis 9.7
594 mixed connective tissue disease 9.7
595 empty sella syndrome 9.7
596 gastric adenocarcinoma 9.7
597 anovulation 9.7
598 craniopharyngioma 9.7
599 thrombophlebitis 9.7
600 pseudohypoparathyroidism 9.7
601 glucose metabolism disease 9.7
602 spindle cell sarcoma 9.7
603 atrophic rhinitis 9.7
604 human immunodeficiency virus infectious disease 9.7
605 severe combined immunodeficiency 9.7
606 acquired immunodeficiency syndrome 9.7
607 diffuse idiopathic skeletal hyperostosis 9.7
608 b-cell lymphoma 9.7
609 osteochondrosis 9.7
610 bullous pemphigoid 9.7
611 duodenitis 9.7
612 subacute delirium 9.7
613 myeloid leukemia 9.7
614 intermediate coronary syndrome 9.7
615 hard palate cancer 9.7
616 achalasia 9.7
617 postpartum depression 9.7
618 diabetic neuropathy 9.7
619 dystrophinopathies 9.7
620 satb2-associated syndrome 9.7
621 sickle cell disease 9.7
622 chronic graft versus host disease 9.7
623 congenital hydrocephalus 9.7
624 glioma 9.7
625 secondary adrenal insufficiency 9.7
626 skeletal dysplasias 9.7
627 spondylarthropathy 9.7
628 stevens-johnson syndrome/toxic epidermal necrolysis 9.7
629 tuberculous meningitis 9.7
630 multiple endocrine neoplasia 9.7
631 headache 9.7
632 pituitary tumors 9.7
633 postherpetic neuralgia 9.7
634 seizure disorder 9.7
635 glial tumor 9.7
636 progeroid syndrome 9.7
637 cerebrofacial arteriovenous metameric syndrome 9.7
638 glomerular disease 9.7
639 undetermined colitis 9.7
640 neurofibromatosis, type ii 9.6
641 pseudohypoparathyroidism, type ia 9.6
642 angelman syndrome 9.6
643 epidermolytic hyperkeratosis 9.6
644 burkitt lymphoma 9.6
645 arthrogryposis, distal, type 3 9.6
646 cardiac arrhythmia 9.6
647 carpal tunnel syndrome 9.6
648 leukocyte adhesion deficiency, type i 9.6
649 chiari malformation type i 9.6
650 coloboma of macula 9.6
651 corneal dystrophy, epithelial basement membrane 9.6
652 ehlers-danlos syndrome, classic type, 1 9.6
653 exostoses, multiple, type ii 9.6
654 exudative vitreoretinopathy 1 9.6
655 factor viii deficiency 9.6
656 fibrodysplasia ossificans progressiva 9.6
657 hair whorl 9.6
658 hypogonadotropic hypogonadism 7 with or without anosmia 9.6
659 multiple system atrophy 1 9.6
660 ichthyosis vulgaris 9.6
661 hyper-ige recurrent infection syndrome 1, autosomal dominant 9.6
662 jacobsen syndrome 9.6
663 leukemia, chronic lymphocytic 9.6
664 lipomatosis, multiple symmetric 9.6
665 moebius syndrome 9.6
666 facioscapulohumeral muscular dystrophy 1 9.6
667 myelopathy, htlv-1-associated 9.6
668 oculopharyngeal muscular dystrophy 9.6
669 gnathodiaphyseal dysplasia 9.6
670 otitis media 9.6
671 papillomatosis, confluent and reticulated 9.6
672 parkinson disease, late-onset 9.6
673 pityriasis rubra pilaris 9.6
674 protoporphyria, erythropoietic, 1 9.6
675 protrusio acetabuli 9.6
676 pulmonary hypertension, primary, 1 9.6
677 dowling-degos disease 1 9.6
678 retinoblastoma 9.6
679 schistosoma mansoni infection, susceptibility/ 9.6
680 spondyloepimetaphyseal dysplasia, strudwick type 9.6
681 syringomyelia, noncommunicating isolated 9.6
682 thrombophilia due to activated protein c resistance 9.6
683 tobacco addiction 9.6
684 trigeminal neuralgia 9.6
685 tuberous sclerosis 1 9.6
686 urate oxidase, pseudogene 9.6
687 varicose veins 9.6
688 vitreoretinopathy, neovascular inflammatory 9.6
689 von hippel-lindau syndrome 9.6
690 neuropathy, hereditary sensory and autonomic, type iia 9.6
691 craniodiaphyseal dysplasia 9.6
692 neuropathy, hereditary sensory and autonomic, type iii 9.6
693 enterocolitis 9.6
694 galactorrhea 9.6
695 glycogen storage disease ii 9.6
696 renal glucosuria 9.6
697 lymphoma, hodgkin, classic 9.6
698 hutterite cerebroosteonephrodysplasia syndrome 9.6
699 hydrocephalus, normal-pressure 9.6
700 mckusick-kaufman syndrome 9.6
701 chylomicron retention disease 9.6
702 familial mediterranean fever 9.6
703 muscular dystrophy, limb-girdle, autosomal recessive 2 9.6
704 myelofibrosis 9.6
705 neuroblastoma 1 9.6
706 ocular motor apraxia 9.6
707 gyrate atrophy of choroid and retina 9.6
708 osteogenesis imperfecta, type iii 9.6
709 osteoid osteoma 9.6
710 osteopetrosis, autosomal recessive 1 9.6
711 pancreatic cancer 9.6
712 laron syndrome 9.6
713 pseudovaginal perineoscrotal hypospadias 9.6
714 sjogren syndrome 9.6
715 taurodontism 9.6
716 spondylocostal dysostosis 1, autosomal recessive 9.6
717 xeroderma pigmentosum, variant type 9.6
718 alopecia, congenital 9.6
719 coats disease 9.6
720 hemophilia a 9.6
721 hemophilia b 9.6
722 lowe oculocerebrorenal syndrome 9.6
723 norrie disease 9.6
724 thoracoabdominal syndrome 9.6
725 kearns-sayre syndrome 9.6
726 oncocytoma 9.6
727 deafness, aminoglycoside-induced 9.6
728 gonadal agenesis 9.6
729 gallbladder disease 1 9.6
730 transsexuality 9.6
731 suppression of tumorigenicity 12 9.6
732 hypocalcemia, autosomal dominant 1 9.6
733 dental anomalies and short stature 9.6
734 dermatitis herpetiformis, familial 9.6
735 leukemia, acute myeloid 9.6
736 bone mineral density quantitative trait locus 1 9.6
737 hemochromatosis, type 2a 9.6
738 ossification of the posterior longitudinal ligament of spine 9.6
739 macular degeneration, age-related, 1 9.6
740 cervical cancer 9.6
741 chudley-mccullough syndrome 9.6
742 aceruloplasminemia 9.6
743 orthostatic intolerance 9.6
744 huntington disease-like 3 9.6
745 lymphoma, non-hodgkin, familial 9.6
746 paragangliomas 3 9.6
747 late-onset retinal degeneration 9.6
748 bone mineral density quantitative trait locus 2 9.6
749 genitopatellar syndrome 9.6
750 muscular dystrophy-dystroglycanopathy , type c, 5 9.6
751 epileptic encephalopathy, early infantile, 6 9.6
752 carotid intimal medial thickness 2 9.6
753 severe cutaneous adverse reaction 9.6
754 leukoencephalopathy, arthritis, colitis, and hypogammaglobulinema 9.6
755 carney complex variant 9.6
756 aplastic anemia 9.6
757 asthma-related traits 4 9.6
758 osteogenesis imperfecta, type v 9.6
759 bone mineral density quantitative trait locus 7 9.6
760 glass syndrome 9.6
761 lung cancer susceptibility 3 9.6
762 alpha-1-antitrypsin deficiency 9.6
763 complement component 3 deficiency, autosomal recessive 9.6
764 microcephaly, epilepsy, and diabetes syndrome 9.6
765 myelodysplastic syndrome 9.6
766 pulmonary fibrosis and/or bone marrow failure, telomere-related, 2 9.6
767 leptin deficiency or dysfunction 9.6
768 leptin receptor deficiency 9.6
769 retinal dystrophy, iris coloboma, and comedogenic acne syndrome 9.6
770 osteogenesis imperfecta, type xv 9.6
771 seizures, scoliosis, and macrocephaly/microcephaly syndrome 9.6
772 spastic paraplegia, intellectual disability, nystagmus, and obesity 9.6
773 hyperparathyroidism 4 9.6
774 helix syndrome 9.6
775 encephalopathy, progressive, early-onset, with episodic rhabdomyolysis 9.6
776 angina pectoris 9.6
777 tendinitis 9.6
778 tendinosis 9.6
779 kashin-beck disease 9.6
780 erythema multiforme 9.6
781 loeys-dietz syndrome 9.6
782 variola major 9.6
783 congenital generalized lipodystrophy 9.6
784 limb ischemia 9.6
785 colorectal adenoma 9.6
786 fibroma 9.6
787 autism spectrum disorder 9.6
788 paraphilia disorder 9.6
789 alexithymia 9.6
790 microscopic colitis 9.6
791 ileitis 9.6
792 persistent hyperplastic primary vitreous 9.6
793 parietal foramina 9.6
794 pollen allergy 9.6
795 drug allergy 9.6
796 autosomal recessive congenital ichthyosis 9.6
797 muscular disease 9.6
798 acromesomelic dysplasia 9.6
799 superior semicircular canal dehiscence 9.6
800 hemochromatosis type 2 9.6
801 corneal disease 9.6
802 dry eye syndrome 9.6
803 cholelithiasis 9.6
804 tuberculoid leprosy 9.6
805 pneumoconiosis 9.6
806 anthracosis 9.6
807 yaws 9.6
808 bacterial infectious disease 9.6
809 protein-losing enteropathy 9.6
810 open-angle glaucoma 9.6
811 chronic pyelonephritis 9.6
812 chronic frontal sinusitis 9.6
813 frontal sinusitis 9.6
814 lepromatous leprosy 9.6
815 transsexualism 9.6
816 lipoid nephrosis 9.6
817 discitis 9.6
818 pulpitis 9.6
819 allergic conjunctivitis 9.6
820 erysipelas 9.6
821 tetanus 9.6
822 bladder calculus 9.6
823 pyelonephritis 9.6
824 diphtheria 9.6
825 horner's syndrome 9.6
826 autonomic neuropathy 9.6
827 chondrocalcinosis 9.6
828 hyperandrogenism 9.6
829 palindromic rheumatism 9.6
830 protein-energy malnutrition 9.6
831 postmenopausal atrophic vaginitis 9.6
832 neurogenic bladder 9.6
833 common variable immunodeficiency 9.6
834 oligohydramnios 9.6
835 cartilage disease 9.6
836 spinal muscular atrophy 9.6
837 tarsal tunnel syndrome 9.6
838 vestibular neuronitis 9.6
839 locked-in syndrome 9.6
840 leiomyoma 9.6
841 sialolithiasis 9.6
842 scleritis 9.6
843 tuberous sclerosis 9.6
844 eclampsia 9.6
845 patent foramen ovale 9.6
846 sick sinus syndrome 9.6
847 polyneuropathy 9.6
848 schistosomiasis 9.6
849 iritis 9.6
850 toxic shock syndrome 9.6
851 frozen shoulder 9.6
852 hypophosphatasia 9.6
853 ochronosis 9.6
854 shoulder impingement syndrome 9.6
855 46 xx gonadal dysgenesis 9.6
856 labyrinthitis 9.6
857 cholera 9.6
858 avoidant personality disorder 9.6
859 personality disorder 9.6
860 thrombocytopenia due to platelet alloimmunization 9.6
861 keratosis 9.6
862 ventricular septal defect 9.6
863 heart septal defect 9.6
864 neuroendocrine tumor 9.6
865 mitral valve stenosis 9.6
866 thyroid gland cancer 9.6
867 giant cell tumor 9.6
868 neuroma 9.6
869 encephalomalacia 9.6
870 post-traumatic stress disorder 9.6
871 hereditary multiple exostoses 9.6
872 essential thrombocythemia 9.6
873 myeloproliferative neoplasm 9.6
874 thrombocytosis 9.6
875 hepatitis 9.6
876 gastroenteritis 9.6
877 generalized atherosclerosis 9.6
878 hyperpituitarism 9.6
879 basal cell carcinoma 9.6
880 orchitis 9.6
881 testicular disease 9.6
882 agammaglobulinemia 9.6
883 kidney cancer 9.6
884 myoma 9.6
885 bilirubin metabolic disorder 9.6
886 auditory system disease 9.6
887 glycogen storage disease 9.6
888 nonspecific interstitial pneumonia 9.6
889 bruxism 9.6
890 severe acute respiratory syndrome 9.6
891 pulmonary tuberculosis 9.6
892 bursitis 9.6
893 cystic kidney disease 9.6
894 papillary carcinoma 9.6
895 cutis laxa 9.6
896 skin squamous cell carcinoma 9.6
897 tropical spastic paraparesis 9.6
898 lysosomal storage disease 9.6
899 demyelinating disease 9.6
900 myelitis 9.6
901 causalgia 9.6
902 lipid pneumonia 9.6
903 syringomyelia 9.6
904 central nervous system disease 9.6
905 bacterial vaginosis 9.6
906 palmoplantar keratosis 9.6
907 breast disease 9.6
908 plague 9.6
909 necrobiosis lipoidica 9.6
910 chronic wasting disease 9.6
911 superior mesenteric artery syndrome 9.6
912 olfactory neuroblastoma 9.6
913 leukorrhea 9.6
914 vaginal discharge 9.6
915 lung squamous cell carcinoma 9.6
916 dentinogenesis imperfecta 9.6
917 intracranial thrombosis 9.6
918 hypertrichosis 9.6
919 carcinosarcoma 9.6
920 polyradiculoneuropathy 9.6
921 seminoma 9.6
922 macular retinal edema 9.6
923 bartter disease 9.6
924 pseudohypoaldosteronism 9.6
925 persian gulf syndrome 9.6
926 hypotrichosis 9.6
927 familial retinoblastoma 9.6
928 uremia 9.6
929 calciphylaxis 9.6
930 aggressive systemic mastocytosis 9.6
931 movement disease 9.6
932 eunuchism 9.6
933 ovarian cyst 9.6
934 chronic inflammatory demyelinating polyradiculoneuropathy 9.6
935 eye disease 9.6
936 adenosine deaminase deficiency 9.6
937 hemolytic anemia 9.6
938 brown-sequard syndrome 9.6
939 acute stress disorder 9.6
940 epithelioid sarcoma 9.6
941 conjunctivitis 9.6
942 reactive arthritis 9.6
943 renal oncocytoma 9.6
944 combined t cell and b cell immunodeficiency 9.6
945 inherited metabolic disorder 9.6
946 kummell's disease 9.6
947 myositis ossificans 9.6
948 compartment syndrome 9.6
949 mitochondrial metabolism disease 9.6
950 premenstrual tension 9.6
951 active peptic ulcer disease 9.6
952 childhood leukemia 9.6
953 complement component 3 deficiency 9.6
954 retinal degeneration 9.6
955 localized scleroderma 9.6
956 dermatitis herpetiformis 9.6
957 nervous system disease 9.6
958 smallpox 9.6
959 fascioliasis 9.6
960 viral infectious disease 9.6
961 exophthalmos 9.6
962 acute myocardial infarction 9.6
963 diabetes insipidus 9.6
964 fasciitis 9.6
965 necrotizing fasciitis 9.6
966 pathologic nystagmus 9.6
967 tenosynovitis 9.6
968 peripheral vertigo 9.6
969 alopecia areata 9.6
970 hypereosinophilic syndrome 9.6
971 microcephaly 9.6
972 myotonic dystrophy 9.6
973 cleidocranial dysplasia spectrum disorder 9.6
974 hypermobile ehlers-danlos syndrome 9.6
975 isolated gonadotropin-releasing hormone deficiency 9.6
976 juvenile hereditary hemochromatosis 9.6
977 kat6b-related disorders 9.6
978 mitochondrial disorders 9.6
979 multiple epiphyseal dysplasia, recessive 9.6
980 spondylocostal dysostosis, autosomal recessive 9.6
981 allergic encephalomyelitis 9.6
982 anterior uveitis 9.6
983 arachnoid cysts 9.6
984 central congenital hypothyroidism 9.6
985 chiari malformation 9.6
986 chromosomal triplication 9.6
987 chromosome 20p duplication 9.6
988 chronic inflammatory demyelinating polyneuropathy 9.6
989 dentinogenesis imperfecta type 2 9.6
990 dwarfism 9.6
991 epilepsy progressive myoclonic type 3 9.6
992 germ cells tumors 9.6
993 glossodynia 9.6
994 heparin-induced thrombocytopenia 9.6
995 homologous wasting disease 9.6
996 htlv-1 associated myelopathy/tropical spastic paraparesis 9.6
997 hyperadrenalism 9.6
998 idiopathic neutropenia 9.6
999 lathyrism 9.6
1000 leukemia, b-cell, chronic 9.6
1001 lymphangiectasis 9.6
1002 medullary sponge kidney 9.6
1003 myotonia atrophica 9.6
1004 ovarian epithelial cancer 9.6
1005 precocious puberty 9.6
1006 primary intestinal lymphangiectasia 9.6
1007 pseudohypoparathyroidism with albright hereditary osteodystrophy 9.6
1008 pure autonomic failure 9.6
1009 pustular psoriasis 9.6
1010 slc4a1-associated distal renal tubular acidosis 9.6
1011 spastic paraparesis 9.6
1012 sudden sensorineural hearing loss 9.6
1013 synovial chondromatosis 9.6
1014 thrombasthenia 9.6
1015 transverse myelitis 9.6
1016 raynaud phenomenon 9.6
1017 bunion 9.6
1018 combined pituitary hormone deficiency 9.6
1019 cytomegalovirus infection 9.6
1020 dysautonomia 9.6
1021 posttransplant acute limbic encephalitis 9.6
1022 congenital hypogonadotropic hypogonadism 9.6
1023 familial calcium pyrophosphate deposition 9.6
1024 isolated bone marrow mastocytosis 9.6
1025 autosomal dominant epidermolytic ichthyosis 9.6
1026 autosomal recessive malignant osteopetrosis 9.6
1027 bone sarcoma 9.6
1028 amelia 9.6
1029 eosinophilic colitis 9.6
1030 traumatic avascular necrosis 9.6
1031 idiopathic avascular necrosis 9.6
1032 erythema multiforme major 9.6
1033 autoimmune hypoparathyroidism 9.6
1034 acute liver failure 9.6
1035 moderate and severe traumatic brain injury 9.6
1036 x-linked intellectual disability-macrocephaly-macroorchidism syndrome 9.6
1037 acute adrenal insufficiency 9.6

Graphical network of the top 20 diseases related to Bone Mineral Density Quantitative Trait Locus 8:



Diseases related to Bone Mineral Density Quantitative Trait Locus 8

Symptoms & Phenotypes for Bone Mineral Density Quantitative Trait Locus 8

Clinical features from OMIM:

611739

UMLS symptoms related to Bone Mineral Density Quantitative Trait Locus 8:


tremor, angina pectoris, back pain, sciatica, equilibration disorder, muscle cramp, pelvic pain

Drugs & Therapeutics for Bone Mineral Density Quantitative Trait Locus 8

Drugs for Bone Mineral Density Quantitative Trait Locus 8 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 647, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Linagliptin Approved Phase 4 668270-12-0 10096344
2
Magnesium oxide Approved Phase 4 1309-48-4 14792
3
Dinoprostone Approved Phase 4 363-24-6 5280360
4
Teriparatide Approved, Investigational Phase 4 52232-67-4 16133850
5
Risedronate Approved, Investigational Phase 4 105462-24-6 5245
6
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
7
Polyestradiol phosphate Approved Phase 4 28014-46-2
8
Esomeprazole Approved, Investigational Phase 4 119141-88-7, 161796-78-7, 161973-10-0 9568614 4594
9
Tibolone Approved, Investigational Phase 4 5630-53-5
10
Atorvastatin Approved Phase 4 134523-00-5 60823
11
Acetaminophen Approved Phase 4 103-90-2 1983
12
Etanercept Approved, Investigational Phase 4 185243-69-0
13
Pamidronate Approved Phase 4 40391-99-9 4674
14
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
15
Montelukast Approved Phase 4 158966-92-8 5281040
16
Adalimumab Approved Phase 4 331731-18-1 16219006
17
Norethindrone Approved Phase 4 68-22-4 6230
18
Potassium Citrate Approved, Investigational, Vet_approved Phase 4
19
Fluticasone Approved, Experimental Phase 4 90566-53-3 62924
20
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
21
Angiotensin II Approved, Investigational Phase 4 11128-99-7, 68521-88-0, 4474-91-3 172198
22
Valsartan Approved, Investigational Phase 4 137862-53-4 60846
23
Olanzapine Approved, Investigational Phase 4 132539-06-1 4585
24
Bupivacaine Approved, Investigational Phase 4 2180-92-9, 38396-39-3 2474
25
Oxycodone Approved, Illicit, Investigational Phase 4 76-42-6 5284603
26
Dopamine Approved Phase 4 51-61-6, 62-31-7 681
27
Aripiprazole Approved, Investigational Phase 4 129722-12-9 60795
28
Gliclazide Approved Phase 4 21187-98-4 3475
29
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
30
Lamivudine Approved, Investigational Phase 4 134678-17-4 60825
31
Basiliximab Approved, Investigational Phase 4 152923-56-3, 179045-86-4
32
Peginterferon alfa-2a Approved, Investigational Phase 4 198153-51-4 5360545
33
Ribavirin Approved Phase 4 36791-04-5 37542
34
Ritonavir Approved, Investigational Phase 4 155213-67-5 392622
35
Liraglutide Approved Phase 4 204656-20-2 44147092
36
Azathioprine Approved Phase 4 446-86-6 2265
37
Darunavir Approved Phase 4 206361-99-1, 635728-49-3 213039
38
Perindopril Approved Phase 4 107133-36-8, 82834-16-0 107807
39
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
40
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
41
Gabapentin Approved, Investigational Phase 4 60142-96-3 3446
42
Hydromorphone Approved, Illicit Phase 4 466-99-9 5284570